Device
AcrySof® IQ PanOptix®
AcrySof® IQ PanOptix® is a medical device with 2 clinical trials. Currently 1 active trials ongoing.
Total Trials
2
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Active Trials
1(50%)
Phase Distribution
Ph not_applicable
2
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
2
all time
Status Distribution
Active(1)
Other(1)
Detailed Status
Recruiting1
unknown1
Development Timeline
Analytics
Development Status
Total Trials
2
Active
1
Success Rate
N/A
Most Advanced
N/A
Trials by Phase
N/A2 (100.0%)
Trials by Status
recruiting150%
unknown150%
Recent Activity
1 active trials
Showing 2 of 2
recruitingnot_applicable
A Planned Study at Multiple Sites is Being Done to Compare the Results of Two Types of Trifocal Toric Intraocular Lenses Used in Cataract Surgery
NCT07232615
unknownnot_applicable
Prospective Evaluation and Comparison of Bilateral Synergy Implants and Bilateral PanOptix Implants
NCT05186298
Clinical Trials (2)
Showing 2 of 2 trials
NCT07232615Not Applicable
A Planned Study at Multiple Sites is Being Done to Compare the Results of Two Types of Trifocal Toric Intraocular Lenses Used in Cataract Surgery
NCT05186298Not Applicable
Prospective Evaluation and Comparison of Bilateral Synergy Implants and Bilateral PanOptix Implants
All 2 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 2